Set alpha/beta-mrna isoform ratio by a novel qpcr assay has prognostic significance in chronic lymphocytic leukemia and may be modulated by treatment
Publication
, Journal Article
Brander, D; Christensen, D; Volkheimer, A; Stewart, T; Chen, Y; Friedman, D; Weinberg, JB
Published in: LEUKEMIA & LYMPHOMA
September 1, 2015
Duke Scholars
Published In
LEUKEMIA & LYMPHOMA
EISSN
1029-2403
ISSN
1042-8194
Publication Date
September 1, 2015
Volume
56
Start / End Page
121 / 122
Publisher
TAYLOR & FRANCIS LTD
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Brander, D., Christensen, D., Volkheimer, A., Stewart, T., Chen, Y., Friedman, D., & Weinberg, J. B. (2015). Set alpha/beta-mrna isoform ratio by a novel qpcr assay has prognostic significance in chronic lymphocytic leukemia and may be modulated by treatment. LEUKEMIA & LYMPHOMA, 56, 121–122.
Brander, Danielle, Dale Christensen, Alicia Volkheimer, TIffany Stewart, Youwei Chen, Daphne Friedman, and J Brice Weinberg. “Set alpha/beta-mrna isoform ratio by a novel qpcr assay has prognostic significance in chronic lymphocytic leukemia and may be modulated by treatment.” LEUKEMIA & LYMPHOMA 56 (September 1, 2015): 121–22.
Brander D, Christensen D, Volkheimer A, Stewart T, Chen Y, Friedman D, et al. Set alpha/beta-mrna isoform ratio by a novel qpcr assay has prognostic significance in chronic lymphocytic leukemia and may be modulated by treatment. LEUKEMIA & LYMPHOMA. 2015 Sep 1;56:121–2.
Brander, Danielle, et al. “Set alpha/beta-mrna isoform ratio by a novel qpcr assay has prognostic significance in chronic lymphocytic leukemia and may be modulated by treatment.” LEUKEMIA & LYMPHOMA, vol. 56, TAYLOR & FRANCIS LTD, Sept. 2015, pp. 121–22.
Brander D, Christensen D, Volkheimer A, Stewart T, Chen Y, Friedman D, Weinberg JB. Set alpha/beta-mrna isoform ratio by a novel qpcr assay has prognostic significance in chronic lymphocytic leukemia and may be modulated by treatment. LEUKEMIA & LYMPHOMA. TAYLOR & FRANCIS LTD; 2015 Sep 1;56:121–122.
Published In
LEUKEMIA & LYMPHOMA
EISSN
1029-2403
ISSN
1042-8194
Publication Date
September 1, 2015
Volume
56
Start / End Page
121 / 122
Publisher
TAYLOR & FRANCIS LTD
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences